Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-15T07:28:59.818Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (December 2007)

Published online by Cambridge University Press:  01 May 2008

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 11 , Issue 5 , May 2008 , e8
Copyright
Copyright © Cambridge University Press 2008

References

1.Antoniou, AC, Sinilnikova, OM, Simard, J, Leone, M, Dumont, M, Neuhausen, SL, Struewing, JP, Stoppa-Lyonnet, D, Barjhoux, L, Hughes, DJ, Coupier, I, Belotti, M, Lasset, C, Rebbeck, TR, Wagner, T, Lynch, HT, Domchek, SM, Nathanson, KL, Garber, JE, Weitzel, J, Narod, SA, Tomlinson, G, Olopade, OI, Godwin, A, Isaacs, C, Jakubowska, A, Lubinski, J, Gronwald, J, Gorski, B, Byrski, T, Huzarski, T, Peock, S, Cook, M, Baynes, C, Murray, A, Rogers, M, Daly, PA, Dorkins, H, Schmutzler, RK, Versmold, B, Engel, C, Meindl, A, Arnold, N, Niederacher, D, Deissler, H, Spurdle, AB, Chen, XQ, Waddell, N, Cloonan, N, Kirchhoff, T, Offit, K, Friedman, E, Kaufmann, B, Laitman, Y, Galore, G, Rennert, G, Lejbkowicz, F, Raskin, L, Andrulis, IL, Ilyushik, E, Ozcelik, H, Devilee, P, Vreeswijk, MPG, Greene, MH, Prindiville, SA, Osorio, A, Benitez, J, Zikan, M, Szabo, CI, Kilpivaara, O, Nevanlinna, H, Hamann, U, Durocher, F, Arason, A, Couch, FJ, Easton, DF, Chenevix-Trench, G. RADS1 135G -> C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007; 81: 1186–1200.CrossRefGoogle Scholar
2.Bayliss, J, Hilger, A, Vishnu, P, Diehl, K, El Ashry, D. Reversal of the estrogen receptor-negative phenotype in breast cancer and restoration of antiestrogen response. Clin Cancer Res 2007; 13: 7029–7036.CrossRefGoogle ScholarPubMed
3.Belguise, K, Sonenshein, GE. PKC θ promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis. J Clin Invest 2007; 117: 4009–4021.Google Scholar
4.Bell, DW, Kim, SH, Godwin, AK, Schiripo, TA, Harris, PL, Haserlat, SM, Wahrer, DCR, Haiman, CA, Daly, MB, Niendorf, KB, Smith, MR, Sgroi, DC, Garber, JE, Olopade, OI, Le Marchand, L, Henderson, BE, Altshuler, D, Haber, DA, Freedman, ML. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 2007; 121: 2661–2667.CrossRefGoogle ScholarPubMed
5.Croucher, DR, Saunders, DN, Stillfried, GE, Ranson, M. A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells. Biochem J 2007; 408: 203–210.Google Scholar
6.Daniel, AR, Faivre, EJ, Lange, CA. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol Endocrinol 2007; 21: 2890–2906.Google Scholar
7.Dhasarathy, A, Kajita, M, Wade, PA. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-α. Mol Endocrinol 2007; 21: 2907–2918.Google Scholar
8.Dillon, RL, Brown, ST, Ling, C, Shioda, T, Muller, WJ. An EGR2/CITED1 transcription factor complex and the 14-3-3 σ tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer. Mol Cell Biol 2007; 27: 8648–8657.CrossRefGoogle Scholar
9.Gail, MH, Costantino, JP, Pee, D, Bondy, M, Newman, L, Selvan, M, Anderson, GL, Malone, KE, Marchbanks, PA, McCaskill-Stevens, W, Norman, SA, Simon, MS, Spirtas, R, Ursin, G, Bernstein, L. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007; 99: 1782–1792.Google Scholar
10.Gomez, BP, Riggins, RB, Shajahan, AN, Klimach, U, Wang, A, Crawford, AC, Zhu, Y, Zwart, A, Wang, M, Clarke, R. Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J 2007; 21: 4013–4027.Google Scholar
11.Gupta, GP, Perk, J, Acharyya, S, de Candia, P, Mittal, V, Todorova-Manova, K, Gerald, WL, Brogi, E, Benezra, R, Massague, J. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 2007; 104: 19506–19511.CrossRefGoogle ScholarPubMed
12.Heaphy, CM, Baumgartner, KB, Bisoffi, M, Baumgartner, RN, Griffith, JK. Telomere DNA content predicts breast cancer-free survival interval. Clin Cancer Res 2007; 13: 7037–7043.CrossRefGoogle ScholarPubMed
13.Heinonen, M, Fagerholm, R, Aaltonen, K, Kilpivaara, O, Aittomaki, K, Blomqvist, C, Heikkila, P, Haglund, C, Nevanlinna, H, Ristimaki, A. Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res 2007; 13: 6959–6963.Google Scholar
14.Huang, Y, Fernandez, SV, Goodwin, S, Russo, PA, Russo, IH, Sutter, TR, Russo, J. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17 β-estradiol. Cancer Res 2007; 67: 11147–11157.CrossRefGoogle Scholar
15.John, EM, Miron, A, Gong, G, Phipps, AI, Felberg, A, Li, FP, West, DW, Whittemore, AS. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 2007; 298: 2869–2876.Google Scholar
16.John, EM, Schwartz, GG, Koo, J, Wang, W, Ingles, SA. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 2007; 166: 1409–1419.Google Scholar
17.Lin, J, Manson, JE, Selhub, J, Buring, JE, Zhang, SMM. Plasma cysteinylglycine levels and breast cancer risk in women. Cancer Res 2007; 67: 11123–11127.CrossRefGoogle ScholarPubMed
18.MacAusland, SG, Hepel, JT, Chong, FK, Galper, SL, Gass, JS, Ruthazer, R, Wazer, DE. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. Cancer 2007; 110: 2648–2653.CrossRefGoogle Scholar
19.Mori, N, Glunde, K, Takagi, T, Raman, V, Bhujwalla, ZM. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells. Cancer Res 2007; 67: 11284–11290.CrossRefGoogle ScholarPubMed
20.Naiki-Ito, A, Asamoto, M, Hokaiwado, N, Takahashi, S, Yamashita, H, Tsuda, H, Ogawa, K, Shirai, T. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens. Cancer Res 2007; 67: 11353–11358.CrossRefGoogle ScholarPubMed
21.Palmer, CP, Mahen, R, Schnell, E, Djamgoz, MBA, Aydar, E. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 2007; 67: 11166–11175.Google Scholar
22.Patocs, A, Zhang, L, Xu, YM, Weber, F, Caldes, T, Mutter, GL, Platzer, P, Eng, C. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 2007; 357: 2543–2551.Google Scholar
23.Ruhe, JE, Streit, S, Hart, S, Wong, CH, Specht, K, Knyazev, P, Knyazeva, T, Tay, LS, Loo, HL, Foo, P, Wong, W, Pok, S, Lim, SJ, Ong, H, Luo, M, Ho, HV, Peng, K, Lee, TC, Bezler, M, Mann, C, Gaertner, S, Hoefler, H, Iacobelli, S, Peter, S, Tay, A, Brenner, S, Venkatesh, B, Ullrich, A. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Res 2007; 67: 11368–11376.CrossRefGoogle ScholarPubMed
24.Sankaran, S, Crone, DE, Palazzo, RE, Parvin, JD. Aurora – a kinase regulates breast cancer-associated gene 1 inhibition of centrosome-dependent microtubule nucleation. Cancer Res 2007; 67: 11186–11194.Google Scholar
25.Sansone, P, Storci, G, Tavolari, S, Guarnieri, T, Giovannini, C, Taffurelli, M, Ceccarelli, C, Santini, D, Paterini, P, Marcu, KB, Chieco, P, Bonafe, M. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007; 117: 3988–4002.CrossRefGoogle ScholarPubMed
26.Wang, H, Teske, D, Tess, A, Kohlhepp, R, Choi, Y, Kendziorski, C, Moser, AR. Identification of novel modifier loci of ApcMin affecting mammary tumor development. Cancer Res 2007; 67: 11226–11233.CrossRefGoogle ScholarPubMed
27.Westbrook, L, Manuvakhova, M, Kern, FG, Estes, NR, Ramanathan, HN, Thottassery, JV. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells. Cancer Res 2007; 67: 11393–11401.Google Scholar
28.Yokota, T, Bui, TY, Liu, YN, Yi, M, Hunt, KK, Keyomarsi, K. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/Enhancer binding protein β. Cancer Res 2007; 67: 11272–11283.Google Scholar
29.Yokoyama, S, Chen, CJ, Nguyen, T, Shively, JE. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation. Oncogene 2007; 26: 7637–7646.Google Scholar
30.Zuo, T, Liu, RH, Zhang, HM, Chang, X, Liu, Y, Wang, LZ, Zheng, P, Liu, Y. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 2007; 117: 3765–3773.Google ScholarPubMed